UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000048716 |
|---|---|
| Receipt number | R000055507 |
| Scientific Title | Safety evaluation of intake of ONO-SR/PS for healthy adults part1 |
| Date of disclosure of the study information | 2023/11/08 |
| Last modified on | 2022/12/27 16:01:11 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Safety evaluation
Acronym
Safety evaluation
Scientific Title
Safety evaluation of intake of ONO-SR/PS for healthy adults part1
Scientific Title:Acronym
Safety evaluation of intake of ONO-SR/PS part1
Region
| Japan |
Condition
Condition
Healthy adult
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the safety of ONO-SR/PS daily intake, for 4 weeks
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Hematologic test, Blood biochemistry test, Urine test, Blood pressure/pulsation, Weight/body mass index, Medical Interview, before and 4 weeks after intake and 2 weeks after the end of intake period and Adverse events thorough the study
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Dose comparison
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Intake of ONO-SR/PS, recommended daily intake, for 4 weeks
Interventions/Control_2
Intake of ONO-SR/PS 2-fold quantity of recommended daily intake, for 4 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 64 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
(1)Healthy males and females from 20 to 64 years of age
(2)BMI 18 or more and less than 25
Key exclusion criteria
(1)Subjects who constantly use health food richly containing DHA, EPA, astaxanthin and shark liver oil involvement ingredient more than 1 times a week
(2)Subjects who having habit of fish and selfish (including fish roe) more than 4 times a week
(3)Subjects having possibilities for emerging allergy related to the study (e.g., fish, prawns, crab and spawn)
(4)Subjects who having skin disease, sensitive skin on the upper arm or serious diseases for which medication was required
(5)Subjects having a disease requiring treatment or a history of serious diseases for which medication was required
(6)Subjects who have diseases that require constant me dication, or who have a history of serious diseases that required medication treatment except dry eye and cavity protection
(7) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination
(8)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire
(9)Subjects judged as unsuitable for the study based on the results of clinical examination or cardiopulmonary abnormality in the past
(10)Subjects who are participating in other clinical research at the start of this study
(11)Subjects who intend to become pregnant or lactating
(12)Subjects judged as unsuitable for the study by the investigator for other reasons
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | Katsuya |
| Middle name | |
| Last name | Kishikawa |
Organization
ONO PHARMACEUTICAL CO., LTD.
Division name
Business Design Department, System promotion
Zip code
541-8564
Address
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka-shi, Osaka
TEL
06-6263-2924
kishikawa@ono.co.jp
Public contact
Name of contact person
| 1st name | Tamaki |
| Middle name | |
| Last name | Furuhata |
Organization
EP Mediate Co., Ltd.
Division name
Foods Department, Trial Planning Section
Zip code
162-0821
Address
Kagurazaka AK Building 7F., 1-8 Tsukudocho, Shinjuku-ku, Tokyo
TEL
070-3023-8207
Homepage URL
furuhata.tamaki686@eps.co.jp
Sponsor or person
Institute
EP Mediate Co., Ltd
Institute
Department
Personal name
Funding Source
Organization
ONO PHARMACEUTICAL CO., LTD.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Medical Station Clinic Research Ethics Committee
Address
3-12-8, Takaban, Meguroku, Tokyo
Tel
03-6452-2712
nakagawa.akiko297@eps.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 11 | Month | 08 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2022 | Year | 07 | Month | 28 | Day |
Date of IRB
| 2022 | Year | 07 | Month | 28 | Day |
Anticipated trial start date
| 2022 | Year | 08 | Month | 23 | Day |
Last follow-up date
| 2022 | Year | 11 | Month | 08 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2022 | Year | 08 | Month | 22 | Day |
Last modified on
| 2022 | Year | 12 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055507
